Tyndall Capital Partners L P is 10% Owner at Onconova Therapeutics, Inc. (ONTX). They have made 11 open-market trades across 1 company since 2018, most recently 2019-09-24.
CIK 0001219314
2 open-market purchases totalling $9.8M since 2018, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ONTX | 616,389 | $5.7M |
Shares reported on the most recent Form 4, priced at the 2019-09-26 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | -28.4% | -35.4% | -76.0% |
| Scored | 9 | 9 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ONTX | SELL | 2019-09-24 | 2019-09-26 | $1.19 | $20K | -26.7% | -35.8% | -70.5% |
| ONTX | SELL | 2019-09-20 | 2019-09-24 | $1.54 | $289K | -26.1% | -31.8% | -73.5% |
| ONTX | SELL | 2019-09-18 | 2019-09-20 | $2.10 | $210K | -38.6% | -15.9% | -76.7% |
| ONTX | SELL | 2019-09-11 | 2019-09-13 | $2.75 | $3K | -51.9% | -64.8% | -88.6% |
| ONTX | SELL | 2019-09-09 | 2019-09-11 | $2.77 | $1K | -56.3% | -70.1% | -87.7% |
| ONTX | SELL | 2019-09-05 | 2019-09-09 | $2.78 | $15K | -34.0% | -69.4% | -86.7% |
| ONTX | SELL | 2019-07-09 | 2019-07-11 | $2.83 | $31K | -4.9% | -5.3% | -68.7% |
| ONTX | SELL | 2019-06-27 | 2019-07-01 | $3.45 | $5K | -11.1% | -13.2% | -70.5% |
| ONTX | SELL | 2019-06-25 | 2019-06-27 | $3.40 | $5K | -5.7% | -12.5% | -61.3% |
| ONTX | BUY | 2018-04-27 | 2018-05-01 | $0.43 | $8.7M | -8.3% | -2.5% | +9.1% |
| ONTX | BUY | 2018-02-08 | 2018-02-12 | $1.01 | $1.1M | +12.9% | -1.8% | -62.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.